76 related articles for article (PubMed ID: 17804710)
1. Thyroid-stimulating hormone initiated proliferative signals converge in vivo on the mTOR kinase without activating AKT.
Brewer C; Yeager N; Di Cristofano A
Cancer Res; 2007 Sep; 67(17):8002-6. PubMed ID: 17804710
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the phosphatidylinositol 3-kinase, Akt/protein kinase B, FRAP/mammalian target of rapamycin, and ribosomal S6 kinase 1 signaling pathways by thyroid-stimulating hormone (TSH) and stimulating type TSH receptor antibodies in the thyroid gland.
Suh JM; Song JH; Kim DW; Kim H; Chung HK; Hwang JH; Kim JM; Hwang ES; Chung J; Han JH; Cho BY; Ro HK; Shong M
J Biol Chem; 2003 Jun; 278(24):21960-71. PubMed ID: 12668683
[TBL] [Abstract][Full Text] [Related]
3. Octreotide and the mTOR inhibitor RAD001 (everolimus) block proliferation and interact with the Akt-mTOR-p70S6K pathway in a neuro-endocrine tumour cell Line.
Grozinsky-Glasberg S; Franchi G; Teng M; Leontiou CA; Ribeiro de Oliveira A; Dalino P; Salahuddin N; Korbonits M; Grossman AB
Neuroendocrinology; 2008; 87(3):168-81. PubMed ID: 18025810
[TBL] [Abstract][Full Text] [Related]
4. IGF-1-stimulated protein synthesis in oligodendrocyte progenitors requires PI3K/mTOR/Akt and MEK/ERK pathways.
Bibollet-Bahena O; Almazan G
J Neurochem; 2009 Jun; 109(5):1440-51. PubMed ID: 19453943
[TBL] [Abstract][Full Text] [Related]
5. How one TSH receptor antibody induces thyrocyte proliferation while another induces apoptosis.
Morshed SA; Ma R; Latif R; Davies TF
J Autoimmun; 2013 Dec; 47():17-24. PubMed ID: 23958398
[TBL] [Abstract][Full Text] [Related]
6. Comparative proteomic analysis to dissect differences in signal transduction in activating TSH receptor mutations in the thyroid.
Krause K; Boisnard A; Ihling C; Ludgate M; Eszlinger M; Krohn K; Sinz A; Fuhrer D
Int J Biochem Cell Biol; 2012 Feb; 44(2):290-301. PubMed ID: 22074661
[TBL] [Abstract][Full Text] [Related]
7. Critical and diverse involvement of Akt/mammalian target of rapamycin signaling in human lung carcinomas.
Dobashi Y; Suzuki S; Matsubara H; Kimura M; Endo S; Ooi A
Cancer; 2009 Jan; 115(1):107-18. PubMed ID: 19090006
[TBL] [Abstract][Full Text] [Related]
8. Raptor-rictor axis in TGFbeta-induced protein synthesis.
Das F; Ghosh-Choudhury N; Mahimainathan L; Venkatesan B; Feliers D; Riley DJ; Kasinath BS; Choudhury GG
Cell Signal; 2008 Feb; 20(2):409-23. PubMed ID: 18068336
[TBL] [Abstract][Full Text] [Related]
9. TSH-activated signaling pathways in thyroid tumorigenesis.
Rivas M; Santisteban P
Mol Cell Endocrinol; 2003 Dec; 213(1):31-45. PubMed ID: 15062572
[TBL] [Abstract][Full Text] [Related]
10. Amyloid-beta interrupts the PI3K-Akt-mTOR signaling pathway that could be involved in brain-derived neurotrophic factor-induced Arc expression in rat cortical neurons.
Chen TJ; Wang DC; Chen SS
J Neurosci Res; 2009 Aug; 87(10):2297-307. PubMed ID: 19301428
[TBL] [Abstract][Full Text] [Related]
11. Ras signaling through PI3K confers hormone-independent proliferation that is compatible with differentiation.
Cass LA; Meinkoth JL
Oncogene; 2000 Feb; 19(7):924-32. PubMed ID: 10702801
[TBL] [Abstract][Full Text] [Related]
12. Lesion-targeted thrombopoietin potentiates vasculogenesis by enhancing motility and enlivenment of transplanted endothelial progenitor cells via activation of Akt/mTOR/p70S6kinase signaling pathway.
Eguchi M; Masuda H; Kwon S; Shirakura K; Shizuno T; Ito R; Kobori M; Asahara T
J Mol Cell Cardiol; 2008 Nov; 45(5):661-9. PubMed ID: 18773906
[TBL] [Abstract][Full Text] [Related]
13. Estradiol attenuates the focal cerebral ischemic injury through mTOR/p70S6 kinase signaling pathway.
Koh PO; Cho JH; Won CK; Lee HJ; Sung JH; Kim MO
Neurosci Lett; 2008 May; 436(1):62-6. PubMed ID: 18378082
[TBL] [Abstract][Full Text] [Related]
14. Mammalian target of rapamycin is the key effector of phosphatidylinositol-3-OH-initiated proliferative signals in the thyroid follicular epithelium.
Yeager N; Brewer C; Cai KQ; Xu XX; Di Cristofano A
Cancer Res; 2008 Jan; 68(2):444-9. PubMed ID: 18199538
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor-1 (IGF-1) and leucine activate pig myogenic satellite cells through mammalian target of rapamycin (mTOR) pathway.
Han B; Tong J; Zhu MJ; Ma C; Du M
Mol Reprod Dev; 2008 May; 75(5):810-7. PubMed ID: 18033679
[TBL] [Abstract][Full Text] [Related]
16. Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy.
Kemi OJ; Ceci M; Wisloff U; Grimaldi S; Gallo P; Smith GL; Condorelli G; Ellingsen O
J Cell Physiol; 2008 Feb; 214(2):316-21. PubMed ID: 17941081
[TBL] [Abstract][Full Text] [Related]
17. Critical role of cyclin D3 in TSH-dependent growth of thyrocytes and in hyperproliferative diseases of the thyroid gland.
Motti ML; Boccia A; Belletti B; Bruni P; Troncone G; Cito L; Monaco M; Chiappetta G; Baldassarre G; Palombini L; Fusco A; Viglietto G
Oncogene; 2003 Oct; 22(48):7576-86. PubMed ID: 14576819
[TBL] [Abstract][Full Text] [Related]
18. NVP-BEZ235, a dual PI3K/mTOR inhibitor, prevents PI3K signaling and inhibits the growth of cancer cells with activating PI3K mutations.
Serra V; Markman B; Scaltriti M; Eichhorn PJ; Valero V; Guzman M; Botero ML; Llonch E; Atzori F; Di Cosimo S; Maira M; Garcia-Echeverria C; Parra JL; Arribas J; Baselga J
Cancer Res; 2008 Oct; 68(19):8022-30. PubMed ID: 18829560
[TBL] [Abstract][Full Text] [Related]
19. Akt activation protects pancreatic beta cells from AMPK-mediated death through stimulation of mTOR.
Cai Y; Wang Q; Ling Z; Pipeleers D; McDermott P; Pende M; Heimberg H; Van de Casteele M
Biochem Pharmacol; 2008 May; 75(10):1981-93. PubMed ID: 18377870
[TBL] [Abstract][Full Text] [Related]
20. Melatonin prevents ischemic brain injury through activation of the mTOR/p70S6 kinase signaling pathway.
Koh PO
Neurosci Lett; 2008 Oct; 444(1):74-8. PubMed ID: 18721861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
